To view this email as a web page, click here.
Conference Coverage
 
ICER's Leader: Payers Rely on Its Reports about Drugs' Value to Patients
An interview with the founder and president of ICER Steve Pearson, MD.
Read More
 
Specialty Pharmacy Exec: Gene Therapies Require Innovative Payment Strategies
An interview with vice president of pharmaceutical trade relations for Accredo Rob Osborne.
Read More
ADVERTISEMENT
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.